Contact
DMCA
Privacy
Robuta
https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2011/04/26/11/18/Do-Postmarketing-Surveillance-Studies-Represent-Real-World
Do Postmarketing Surveillance Studies Represent Real-World Populations? A Comparison of Patient...
postmarketing surveillance
real world
studies
represent
populations
https://www.ajmc.com/view/postmarketing-surveillance-study-finds-ixazomib-safety-profile-acceptable-in-rrmm
Postmarketing Surveillance Study Finds Ixazomib Safety Profile Acceptable in RRMM | AJMC
Real-world evidence from Japan found ixazomib has an acceptable safety profile in patients with relapsed/refractory multiple myeloma (RRMS).
postmarketing surveillance
study finds
safety profile
ixazomib
acceptable